41 – 50 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension
- Contribution to journal › Article
-
Mark
The Authors' Reply to the Letter “Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis”
- Contribution to journal › Letter
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- Contribution to journal › Article
-
Mark
Impact of bridging with left ventricular assist device on right ventricular function following heart transplantation
- Contribution to journal › Article
-
Mark
Data on plasma tumour and metabolism related proteins’ potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension
- Contribution to journal › Article
- 2021
-
Mark
Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival
- Contribution to journal › Article
-
Mark
Longitudinal changes in risk status in pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension : call for a refined assessment
- Contribution to journal › Article
-
Mark
Echocardiographic assessment of chamber size and ventricular function during the first year after heart transplantation
- Contribution to journal › Article
